Changes in neurofilament 200 and tyrosine hydroxylase expression in the cardiac innervation of diabetic rats during aging

Cardiovasc Pathol. 2018 Jan-Feb:32:38-43. doi: 10.1016/j.carpath.2017.11.003. Epub 2017 Nov 16.

Abstract

Changes in sensory and sympathetic innervation during diabetes mellitus (DM) can be a predictor of arrhythmias, silent myocardial ischemia, and chronic heart failure, but knowledge about these changes is still unsatisfactory. We analyzed whether prolonged DM induces changes in density of sensory and sympathetic nerve terminals of rat's heart and whether it contributes to cardiomyopathy during aging. DM was induced by i/p injecting 55 mg/kg streptozotocin to male Sprague-Dawley rats, while a control group received a citrate buffer. DM in the rats was validated by measuring blood glucose level. Animals were sacrificed after 2 weeks, 2 months, 6 months, and 12 months. Five areas of cardiac sections were analyzed. Antibodies raised against tyrosine hydroxylase (TH) and neurofilament 200 kDa (NF 200) were used to detect sympathetic and sensory fibers. TH immunoreactive fiber density increased in DM groups 2 weeks after induction, reaching a peek after 2 months, while in the later stages of DM (6 and 12 months), there was no significant difference compared to control. NF 200 immunoreactive fiber density increased 2 weeks after induction compared to control. There was no consistent pattern of change during the given period in both the DM or control groups. In the DM group, we found thickening of the left ventricle wall (P<.05) as the sign of cardiomyopathy. Our findings suggest that hyperglycemia as a hallmark of DM in early stages can lead to proliferation of sympathetic and sensory nerve terminals. This finding can contribute to a better understanding of the occurrence of arrhythmias and silent myocardial ischemia in DM.

Keywords: Diabetes mellitus; Innervation; Neurofilament 200 kDa; Neuropathy; Tyrosine hydroxylase.

MeSH terms

  • Aging / metabolism
  • Aging / pathology*
  • Animals
  • Diabetes Mellitus, Experimental
  • Diabetes Mellitus, Type 1 / metabolism
  • Diabetes Mellitus, Type 1 / pathology
  • Diabetic Cardiomyopathies / metabolism*
  • Diabetic Cardiomyopathies / pathology
  • Heart / innervation*
  • Male
  • Myocardium / metabolism
  • Myocardium / pathology
  • Neurofilament Proteins / biosynthesis*
  • Rats
  • Rats, Sprague-Dawley
  • Tyrosine 3-Monooxygenase / biosynthesis*

Substances

  • Neurofilament Proteins
  • neurofilament protein H
  • Tyrosine 3-Monooxygenase